Serial Number | 90149626 |
Word Mark | INSIGNIA |
Filing Date | Monday, August 31, 2020 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, March 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, January 2, 2024 |
Description of Mark | The mark consists of the word "INSIGNIA" in stylized form. |
Goods and Services | Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders |
Goods and Services | Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely, inorganic acids for industrial purposes; DNA and RNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring |
Goods and Services | Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing apparatus and instruments for medical purposes, namely, for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing kits containing diagnostic testing apparatus for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; point of care medical devices for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; screening kits consisting of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; all of the foregoing excluding heart pacemakers and stethoscopes and orthopedic implants and excluding apparatus, instruments and devices for use with orthopedic surgery and excluding surgical staplers and accessories therefor |
Goods and Services | Scientific and technological services and research and design relating thereto, in the field of DNA analysis services for scientific research analysis, and scientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific purposes and medical research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services, for scientific purposes and medical research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom, for scientific purposes and medical research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, relating to the results of scientific and medical experiments and tests, relating to the analysis and evaluation of scientific and medical data, and relating to data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of medical research and genetics; custom design and development of biochemical assays |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 8, 2020 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 8, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 8, 2020 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 8, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SpeeDx Pty Ltd |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Eveleigh NSW2015 AU |
Party Name | SpeeDx Pty Ltd |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Eveleigh NSW2015 AU |
Event Date | Event Description |
Monday, March 11, 2024 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Thursday, February 22, 2024 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
Tuesday, February 20, 2024 | ASSIGNED TO PETITION STAFF |
Tuesday, January 23, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Friday, January 19, 2024 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
Tuesday, January 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 2, 2024 | PUBLISHED FOR OPPOSITION |
Wednesday, December 13, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 19, 2023 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, September 19, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, September 19, 2023 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, September 19, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, September 12, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, September 5, 2023 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Monday, August 21, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, August 21, 2023 | EXAMINER'S AMENDMENT ENTERED |
Monday, August 21, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, August 21, 2023 | EXAMINERS AMENDMENT E-MAILED |
Monday, August 21, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Saturday, August 19, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, August 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, August 18, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Wednesday, May 31, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, May 31, 2023 | FINAL REFUSAL E-MAILED |
Wednesday, May 31, 2023 | FINAL REFUSAL WRITTEN |
Saturday, May 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, May 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, February 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, February 14, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, February 14, 2023 | NON-FINAL ACTION WRITTEN |
Monday, August 8, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, August 8, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, August 8, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, July 27, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Friday, July 22, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Thursday, January 20, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Thursday, July 22, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, July 22, 2021 | LETTER OF SUSPENSION E-MAILED |
Thursday, July 22, 2021 | SUSPENSION LETTER WRITTEN |
Wednesday, July 21, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, July 21, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, July 21, 2021 | ASSIGNED TO LIE |
Tuesday, July 6, 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, July 5, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, January 5, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, January 5, 2021 | NON-FINAL ACTION E-MAILED |
Tuesday, January 5, 2021 | NON-FINAL ACTION WRITTEN |
Monday, January 4, 2021 | ASSIGNED TO EXAMINER |
Thursday, October 8, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, September 3, 2020 | NEW APPLICATION ENTERED |